Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ SH3BP4 Antibody Blocking Peptide
SDP

Catalog No. NBP177031E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP177031E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP177031E Supplier Novus Biologicals™ Supplier No. NBP177031PEP
Add to Cart
Add to Cart

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 18 amino acids near the carboxy terminus of human SH3BP4. Source: Synthetic (Accession #: NP_055336) The SH3BP4 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 23677
Species Human
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-77031. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias BOG25SH3 domain-binding protein 4, EHB10, EH-binding protein 10, SH3-domain binding protein 4, transferrin receptor trafficking protein, Transferrin receptor-trafficking protein, TTP
Gene Symbol SH3BP4
Product Type SH3BP4
Quantity 0.05 mg
Regulatory Status RUO - research use only
Source Synthetic
Termination 18 amino acids near the carboxy terminus of human SH3BP4
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.